The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:1973 December 28, 2000 Number 26
NextNext

Heparin-Induced Thrombocytopenia and Cardiopulmonary Bypass

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In their letter on the use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia, Pötzsch et al. (Aug. 17 issue)1 do not mention whether they obtained informed consent from the subjects in the study. This study posed substantial risk because heparin-induced thrombocytopenia and thrombosis can have devastating consequences. When studies involving substantial risk to subjects are reported in the Correspondence section, it would be reassuring to see it clearly stated that informed consent was obtained.


Irwin Nash, M.D.
Hospital of Saint Raphael
New Haven, CT 06511

References

  1. Pötzsch B, Klövekorn W-P, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 2000;343:515-515. [Free Full Text]

 
The authors and a colleague reply:

. . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.